Strides Pharma Science Limited

BSE
STAR
paper.types.company
Rentabilité sur six mois: -53.35%
Rendement en dividendes: 0.0512%

712.6 ₹

+6.55 ₹ +0.9277%
570.3 ₹
1642 ₹

paper.min_max_per_year

Calendrier des promotions Strides Pharma Science Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

plus de détails
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

ISIN
INE939A01011
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.0512
Дивиденд ао
1.14
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 1.83 8
P/BV 3.44 5
P/E 0 0
Efficacité
Nom Signification Grade
ROA -1.13 0
ROE -3.26 0
ROIC -3.79 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0.0512 0.13
DSI 0.8571 8.57
Croissance moyenne du dividende -60.79 0
Devoir
Nom Signification Grade
Debt/EBITDA 11.07 0
Debt/Ratio 0.4135 10
Debt/Equity 1.82 7
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 43.72 6
Rentabilité Ebitda, % -46.65 0
Rentabilité EPS, % -289.02 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 706.05 ₹ 0 ₹ 0 ₹ 0.93 % 0 % 0 %
common.calendar.number_days.7d 688.65 ₹ 0 ₹ 0 ₹ 3.48 % 0 % 0 %
common.calendar.number_days.30d 654.15 ₹ 651.25 ₹ 732.65 ₹ 8.94 % 0 % 0 %
common.calendar.number_days.90d 647.85 ₹ 577.4 ₹ 732.65 ₹ 9.99 % 0 % 0 %
common.calendar.number_days.180d 1 527.7 ₹ 570.3 ₹ 746.9 ₹ -53.35 % 0 % 0 %
common.calendar.number_days.1y 848.3 ₹ 570.3 ₹ 1 642 ₹ -16 % 0 % 0 %
common.calendar.number_days.3y 326.6 ₹ 272.05 ₹ 1 642 ₹ 118.19 % 0 % 0 %
common.calendar.number_days.5y 334.4 ₹ 266.3 ₹ 1 642 ₹ 113.1 % 0 % 0 %
common.calendar.number_days.10y 0 ₹ 266.3 ₹ 1 642 ₹ 0 % 0 % 0 %
common.calendar.number_days.ytd 690.3 ₹ 570.3 ₹ 746.9 ₹ 3.23 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 année)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 année)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 années)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 années)

Informations sur l'entreprise

Adresse: India, Bengaluru, Strides House - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.strides.com